{
     "PMID": "23190173",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20130826",
     "LR": "20161019",
     "IS": "1600-079X (Electronic) 0742-3098 (Linking)",
     "VI": "54",
     "IP": "2",
     "DP": "2013 Mar",
     "TI": "Melatonin potentiates running wheel-induced neurogenesis in the dentate gyrus of adult C3H/HeN mice hippocampus.",
     "PG": "222-31",
     "LID": "10.1111/jpi.12023 [doi]",
     "AB": "This study assessed the role of melatonin in modulating running wheel(RW)-induced hippocampal neurogenesis in adult C3H/HeN mice. Chronic melatonin (0.02 mg/mL, oral for 12 days) treatment did not affect cell proliferation or cell survival determined by the number of BrdU-positive cells in dentate gyrus of mice with access to fixed wheel (FW). RW activity significantly increased cell proliferation [RW (n = 8) versus FW (n = 6): dorsal, 199 +/- 18 versus 125 +/- 12, P < 0.01; ventral, 211 +/- 15 versus 123 +/- 13, P < 0.01] and newborn cell survival [RW (n = 7) versus FW (n = 8): dorsal, 45 +/- 8.5 versus 15 +/- 1.8, P < 0.01; ventral, 48 +/- 8.1 versus 15 +/- 1.4)] in the dorsal and ventral dentate gyrus. Oral melatonin treatment further potentiated RW activity-induced cell survival in both areas of the dentate gyrus [melatonin (n = 10) versus vehicle (n = 7): dorsal, 63 +/- 5.4 versus 45 +/- 8.5 P < 0.05; ventral, 75 +/- 7.9 versus 48 +/- 8.1, P < 0.01] and neurogenesis [melatonin (n = 8) versus vehicle (n = 8): dorsal, 46 +/- 3.4, versus 34 +/- 4.5, P < 0.05; ventral, 41 +/- 3.4 versus 25 +/- 2.4, P < 0.01]. We conclude that melatonin potentiates RW-induced hippocampal neurogenesis by enhancing neuronal survival suggesting that the combination of physical exercise and melatonin may be an effective treatment for diseases affecting the hippocampus neurogenesis.",
     "CI": [
          "(c) 2012 John Wiley & Sons A/S. Published by Blackwell Publishing Ltd."
     ],
     "FAU": [
          "Liu, Jiabei",
          "Somera-Molina, Kathleen C",
          "Hudson, Randall L",
          "Dubocovich, Margarita L"
     ],
     "AU": [
          "Liu J",
          "Somera-Molina KC",
          "Hudson RL",
          "Dubocovich ML"
     ],
     "AD": "Department of Pharmacology & Toxicology, School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY 14214, USA.",
     "LA": [
          "eng"
     ],
     "GR": [
          "R01 MH042922/MH/NIMH NIH HHS/United States",
          "T32 EY007128/EY/NEI NIH HHS/United States",
          "MH42922/MH/NIMH NIH HHS/United States",
          "T32 EY07128/EY/NEI NIH HHS/United States"
     ],
     "PT": [
          "Journal Article",
          "Research Support, N.I.H., Extramural"
     ],
     "DEP": "20121128",
     "PL": "England",
     "TA": "J Pineal Res",
     "JT": "Journal of pineal research",
     "JID": "8504412",
     "RN": [
          "EC 2.7.11.24 (p38 Mitogen-Activated Protein Kinases)",
          "JL5DK93RCL (Melatonin)"
     ],
     "SB": "IM",
     "MH": [
          "Animals",
          "Blotting, Western",
          "Dentate Gyrus/*cytology",
          "Enzyme-Linked Immunosorbent Assay",
          "Immunohistochemistry",
          "Melatonin/*therapeutic use",
          "Mice",
          "Neuralgia/*drug therapy/metabolism",
          "Neurogenesis/*drug effects",
          "Rats, Sprague-Dawley",
          "p38 Mitogen-Activated Protein Kinases/antagonists & inhibitors/metabolism"
     ],
     "PMC": "PMC3568494",
     "MID": [
          "NIHMS437651"
     ],
     "EDAT": "2012/11/30 06:00",
     "MHDA": "2013/08/27 06:00",
     "CRDT": [
          "2012/11/30 06:00"
     ],
     "PHST": [
          "2012/08/10 00:00 [received]",
          "2012/09/28 00:00 [accepted]",
          "2012/11/30 06:00 [entrez]",
          "2012/11/30 06:00 [pubmed]",
          "2013/08/27 06:00 [medline]"
     ],
     "AID": [
          "10.1111/jpi.12023 [doi]"
     ],
     "PST": "ppublish",
     "SO": "J Pineal Res. 2013 Mar;54(2):222-31. doi: 10.1111/jpi.12023. Epub 2012 Nov 28.",
     "term": "hippocampus"
}